Article Information
History
- September 3, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 3, 2020 - 08:24).
- Version 2 (October 6, 2020 - 10:42).
- Version 3 (January 16, 2021 - 00:48).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Xueting Qiu, PhD1,
- Ali Ihsan Nergiz2,
- Alberto Enrico Maraolo, MD3,
- Isaac I. Bogoch, MD4,
- Nicola Low, MD, MSc, FFPH5 and
- Muge Cevik, MRCP6,*
- 1Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, USA
- 2Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey
- 3First Division of Infectious Diseases, Cotugno Hospital, AORN dei Colli, Naples, Italy
- 4Division of Infectious Diseases, Toronto General Hospital and University of Toronto, Toronto, Canada
- 5Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 6Division of Infection and Global Health Research, School of Medicine, University of St. Andrews, Fife, Scotland, UK
- ↵*
Author of correspondence:
Name: Dr Muge Cevik, Address: Division of Infection and Global Health Research, School of Medicine, University of St Andrews, Fife, Scotland, KY16 9TF Telephone number: +447732800814 Email address: mc349{at}st-andrews.ac.uk
Posted September 03, 2020.
Defining the role of asymptomatic SARS-CoV-2 transmission – a living systematic review
